The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 165.00
Bid: 160.00
Ask: 170.00
Change: 0.00 (0.00%)
Spread: 10.00 (6.25%)
Open: 165.00
High: 165.00
Low: 165.00
Prev. Close: 165.00
HUW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reinsurance Agreement

26 Jul 2013 11:21

RNS Number : 2468K
Hampden Underwriting Plc
26 July 2013
 



26 July 2013

 

Hampden Underwriting PLC

("Hampden Underwriting" or the "Company")

 

Reinsurance releases capital for reinvestment in new opportunities

 

Hampden Underwriting, which provides investors with a limited liability direct investment into the Lloyd's insurance market, is pleased to announce the significant release of capital achieved by way of an annually renewable reinsurance arrangement.

 

Overview of the transaction

 

§ Collateralised quota share reinsurance agreement commencing with 2013 year of account

§ 50% of the Company's 2013 insurance exposure ceded to reinsurer

§ Release of £4.1m (approximately 50%) of the Company's £8.2m of Funds at Lloyd's) for reinvestment in new opportunities

§ Ratcheted, performance-based profit commission payable to the Company of between 10% and 20% of the profits arising on business ceded in each period

§ Minimum term of one year renewable annually thereafter

 

 

Commenting upon this transaction Sir Michael Oliver, the Company's Chairman, said:

"This transaction presents Hampden Underwriting with a welcome source of capital with which to fund near-term opportunities the Company wishes to pursue and does so on attractive commercial terms. The Board regularly considers the relative merits of alternative sources of capital and is confident that this is an appropriate funding option at this time."

 

Commenting upon this transaction Nigel Hanbury, the Company's Chief Executive, said:

 

"Current market conditions continue to present the Company with attractive investment opportunities which require funding. We are delighted to have been able to successfully conclude this transaction which provides the Company with a modest war chest with which we can continue to progress acquisition opportunities. The reinsurance terms provide a profit commission in good underwriting years and a reduced risk exposure in disappointing underwriting years in a spectrum that is both equitable and commercially attractive. Its annually renewable feature provides Hampden Underwriting with certainty for 2013 as well as the appropriate opportunity to review the arrangement from time to time."

 

 

 

For further information please contact:

Hampden Underwriting

 

Nigel Hanbury

nigel.hanbury@hampdenplc.com

Smith & Williamson Corporate Finance

 

David Jones

020 7131 4000

 

Additional information on the reinsurance arrangements

The Company has entered a reinsurance agreement with Hampden Insurance PCC (Guernsey) Limited - Cell 6 ("Cell 6"), a newly-formed special purpose vehicle. On a back-to-back basis, Cell 6 has reinsured the reinsurance risk with Bermudan reinsurer, XL Re Ltd ("XL"), part of global NYSE-quoted insurer XL Group plc.

 

The key terms of the arrangements are as follows:

- XL will take on via Cell 6 the risks and rewards of 50% of the Company's existing 2013 underwriting activities (although the activities themselves and the underwriting capacity will remain the Company's);

- XL will provide a letter of credit to Lloyd's in an amount of £4.1m (approximately 50% of the Company's existing funds at Lloyd's ("FAL"), enabling an equivalent amount to be released from FAL to the Company;

- XL will pay a profit commission of between 10% and 20% of profits from the business ceded to the Company (via Cell 6) depending on the results of the relevant insurance years of account;

- XL will pay a fee to Cell 6 of 1.5% per year of account of the value of the letter of credit provided to Lloyd's and Cell 6 will pay this on to the Company, less the Company's share of Cell 6's management fees, costs and expenses which is estimated to be approximately £12,500 per annum; and

- the reinsurance arrangements apply to the Company's 2013 year of account and are renewable annually thereafter.

 

Cell 6 is ultimately 51% owned by Nigel Hanbury (a director and 14.8% shareholder in the Company) and 49% by Hampden Capital plc (a 11.9% shareholder in the Company). Nigel Hanbury and a number of Lloyd's underwriting entities ultimately owned by him and his family have entered reinsurance agreements with Cell 6 on a pari passu basis. The terms of the transaction have been approved by the independent members of the Company's board of directors.

 

 

About Hampden Underwriting plc

Hampden Underwriting plc has been incorporated primarily to provide a limited liability direct investment into the Lloyd's insurance market. Hampden Underwriting plc is quoted on the London Stock Exchange's AIM market (ticker: HUW). For further information please visit www.hampdenplc.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUNARROBABUAR
Date   Source Headline
23rd Dec 20137:00 amRNSAcquisition of Two Corporate Members
12th Dec 201311:26 amRNSHolding(s) in Company
6th Dec 20135:51 pmRNSResult of General Meeting
20th Nov 20137:00 amRNSProposed Change of Name
13th Nov 20137:00 amRNSCompletion of Acquisition
17th Oct 20137:00 amRNSAcquisition of Corporate Member
15th Oct 20137:00 amRNSReinsurance Renewal and Acquisitions
26th Sep 20137:00 amRNSHalf Yearly Report
26th Jul 201311:21 amRNSReinsurance Agreement
9th Jul 20137:00 amRNSDirectorate Change
27th Jun 20134:01 pmRNSResult of AGM
24th Jun 201310:27 amRNSDirectorate Change
14th Jun 20135:56 pmRNSHolding(s) in Company
4th Jun 20135:28 pmRNSAnnual Report and Notice of AGM
29th May 20137:00 amRNSFinal Results
23rd Apr 20138:18 amRNSHolding(s) in Company
6th Feb 20137:00 amRNSInvestment Strategy
1st Feb 20135:11 pmRNSHolding(s) in Company
21st Dec 20127:00 amRNSAcquisition of Corporate Member
26th Nov 20127:00 amRNSAcquisition of Corporate Member
16th Oct 20125:24 pmRNSHolding(s) in Company
10th Oct 201211:51 amRNSHolding(s) in Company
2nd Oct 20127:00 amRNSAcquisition & Total Voting Rights
28th Sep 20127:00 amRNSHalf Yearly Report
21st Jun 20124:41 pmRNSAGM Statement
29th May 20129:25 amRNSAnnual Report and Notice of AGM
23rd May 20127:00 amRNSFinal Results
28th Sep 20117:00 amRNSHalf Yearly Report
24th May 20119:27 amRNSPosting of Annual Report
23rd May 20117:00 amRNSFinal Results
6th Jan 20116:25 pmRNSDirector/PDMR Shareholding
10th Dec 20102:42 pmRNSDirector/PDMR Shareholding
6th Dec 20104:33 pmRNSDirector/PDMR Shareholding
30th Sep 20107:00 amRNSHalf Yearly Report
5th Aug 20101:00 pmRNSAcquisition of corporate member
18th Jun 20109:40 amRNSResult of AGM
26th May 20101:16 pmRNSAnnual Report and Notice of AGM
21st May 20101:25 pmRNSDirector/PDMR Shareholding
21st May 20107:00 amRNSFinal Results
29th Sep 20097:00 amRNSHalf Yearly Report
19th Jun 20097:00 amRNSResult of AGM
28th May 200912:15 pmRNSAnnual Report and Notice of AGM
18th May 20097:00 amRNSFinal Results
16th Feb 20099:05 amRNSAcquisition
28th Oct 20083:57 pmRNSDirector Declaration
25th Sep 20087:00 amRNSInterim Results
17th Jun 20087:00 amRNSAvailability of accounts
28th Mar 20087:01 amRNSFinal Results
1st Feb 200810:04 amRNSAcquisition
30th Nov 20074:16 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.